| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 59.67B | 60.53B | 61.35B | 58.27B | 38.64B | 37.94B |
| Gross Profit | 36.64B | 37.81B | 37.59B | 35.58B | 17.92B | 13.66B |
| EBITDA | 2.97B | 3.73B | 3.98B | 3.19B | -19.00M | -7.89B |
| Net Income | 3.25B | 4.01B | 2.79B | 2.15B | 661.00M | -4.99B |
Balance Sheet | ||||||
| Total Assets | 54.96B | 58.20B | 59.78B | 54.41B | 51.63B | 52.93B |
| Cash, Cash Equivalents and Short-Term Investments | 19.08B | 23.71B | 23.28B | 20.90B | 18.77B | 19.65B |
| Total Debt | 6.89B | 7.63B | 7.16B | 7.57B | 7.76B | 6.71B |
| Total Liabilities | 16.39B | 18.90B | 18.52B | 17.98B | 17.70B | 19.46B |
| Stockholders Equity | 38.54B | 39.28B | 41.24B | 36.42B | 33.76B | 33.46B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.47B | 3.98B | 3.87B | -1.81B | -6.12B |
| Operating Cash Flow | 0.00 | 2.68B | 4.42B | 4.21B | -1.64B | -5.66B |
| Investing Cash Flow | 0.00 | 1.63B | -2.34B | -1.05B | -1.36B | 15.76B |
| Financing Cash Flow | 0.00 | -3.87B | -1.40B | -920.00M | 527.00M | -4.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥176.78B | 9.78 | 10.24% | 2.43% | 6.08% | 8.55% | |
77 Outperform | ¥136.87B | 14.56 | 11.70% | 3.59% | 3.96% | -36.24% | |
68 Neutral | ¥54.33B | 7.26 | 18.28% | 6.12% | -6.22% | 679.61% | |
66 Neutral | ¥42.84B | 13.45 | ― | 5.23% | ― | ― | |
66 Neutral | ¥117.21B | 17.53 | 2.80% | 3.38% | >-0.01% | -49.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥228.81B | 39.72 | 5.31% | 2.29% | -6.04% | 146.54% |